Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal Virus-Like-Particle Quadrivalent Influenza Vaccine in Adults
Clinical trial NCT02233816 · COMPLETED
Trial details
- NCT number
- NCT02233816
- Sponsor
- Medicago
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-28
- Primary completion
- 2015-06-22
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.